Leslie V.  Norwalk net worth and biography

Leslie Norwalk Biography and Net Worth

Director of Globus Medical
Leslie V. Norwalk, Esq. has served as a member of our board of directors since September 2023. Ms. Norwalk previously served as a member of the board of directors of NuVasive, Inc. from May 2014 to September 2023.  Ms. Norwalk is currently strategic counsel to Epstein Becker & Green, EBG Advisors and National Health Advisors. She also serves as a healthcare, regulatory and policy advisor to several private equity firms. Ms. Norwalk previously served the Bush Administration as the acting administrator for the Centers for Medicare & Medicaid Services. She managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of Health Care Facilities and other federal health care initiatives. For four years prior to that, she was the agency’s deputy administrator, responsible for the implementation of the hundreds of changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit. Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green where she advised clients on a variety of health policy matters. She also served in the first Bush Administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative. Ms. Norwalk serves as a director of Arvinas, ModivCare and Neurocrine Biosciences, as well as several privately held healthcare companies. She is also a member of APCO Worldwide’s International Advisory Council. Ms. Norwalk earned a bachelor’s degree, cum laude, in economics and international relations from Wellesley College and a juris doctor degree from the George Mason University School of Law.

What is Leslie V. Norwalk's net worth?

The estimated net worth of Leslie V. Norwalk is at least $1.21 million as of July 11th, 2024. Ms. Norwalk owns 16,419 shares of Globus Medical stock worth more than $1,213,692 as of October 17th. This net worth estimate does not reflect any other investments that Ms. Norwalk may own. Learn More about Leslie V. Norwalk's net worth.

How do I contact Leslie V. Norwalk?

The corporate mailing address for Ms. Norwalk and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Leslie V. Norwalk's contact information.

Has Leslie V. Norwalk been buying or selling shares of Globus Medical?

Leslie V. Norwalk has not been actively trading shares of Globus Medical during the last quarter. Most recently, Leslie V. Norwalk sold 1,000 shares of the business's stock in a transaction on Thursday, July 11th. The shares were sold at an average price of $70.00, for a transaction totalling $70,000.00. Following the completion of the sale, the director now directly owns 16,419 shares of the company's stock, valued at $1,149,330. Learn More on Leslie V. Norwalk's trading history.

Who are Globus Medical's active insiders?

Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.

Are insiders buying or selling shares of Globus Medical?

During the last year, insiders at the medical device company sold shares 5 times. They sold a total of 109,890 shares worth more than $7,065,787.10. The most recent insider tranaction occured on September, 13th when Director Ann D Rhoads sold 15,000 shares worth more than $1,055,400.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.

Information on this page was last updated on 9/13/2024.

Leslie V. Norwalk Insider Trading History at Globus Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/11/2024Sell1,000$70.00$70,000.0016,419View SEC Filing Icon  
3/15/2024Sell10,590$51.99$550,574.1017,419View SEC Filing Icon  
See Full Table

Leslie V. Norwalk Buying and Selling Activity at Globus Medical

This chart shows Leslie V Norwalk's buying and selling at Globus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Globus Medical Company Overview

Globus Medical logo
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Read More

Today's Range

Now: $73.92
Low: $73.33
High: $74.86

50 Day Range

MA: $70.71
Low: $67.08
High: $74.85

2 Week Range

Now: $73.92
Low: $43.38
High: $75.98

Volume

969,716 shs

Average Volume

1,004,342 shs

Market Capitalization

$10.01 billion

P/E Ratio

246.40

Dividend Yield

N/A

Beta

1.17